The two coronavirus vaccines are among several candidates in final-stage testing, the last step before seeking regulatory approval.
FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S.
The drugmakers said they got the go-ahead Friday from the Food and Drug Administration to restart tests in the U.S. Testing of the AstraZeneca vaccine, developed with Oxford University, has already resumed in the United Kingdom, Brazil, South Africa and Japan. AstraZeneca’s study involves 30,000 people in the U.S., with some getting the vaccine and others a dummy shot.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca, J&J resume tests of Covid-19 vaccines in US – latest updatesAstraZeneca, J&J resume US tests of their coronavirus vaccine candidates. Other Covid19 updates: 🇲🇽 Mexico reports 6,604 new cases, 418 deaths 🇧🇷 Brazil reports 30,026 new cases, 571 deaths 🇹🇷 Turkey sees 2nd Covid-19 peak in Anatolian region More here:
Read more »
WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter.
Read more »
AstraZeneca resumes U.S. COVID-19 vaccine trial, optimism seen for J&JAstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by U.S. regulators, the company said on Friday.
Read more »
AstraZeneca will resume its Covid-19 vaccine trial in the USThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »
AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJFederal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Read more »
AstraZeneca resumes U.S. Covid-19 vaccine trial and Johnson & Johnson prepares to do sameAstraZeneca has resumed the U.S. trial of its experimental Covid-19 vaccine after approval by U.S. regulators, and an oversight panel has recommended that Johnson & Johnson resume its trial as well, the companies said on Friday.
Read more »